JH
Jason Hoitt
DELAYED 1 MONTH
Chief Patient Officer
Stoke Therapeutics, Inc.
Filings
1
Companies
1
Latest
Mar 15, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Stoke Therapeutics, Inc.
Jason Hoitt
Chief Patient Officer
Option Exercise
—
10,000 sh
Mar 17 9:26 PM
Mar 15, 2026